研究论文

Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin

Alexander Segner, Harpreet S. Bajaj, Joakim Isendahl, Amoolya Gowda, Karolina Stachlewska, Julio Rosenstock

LMC Diabetes & Endocrinology (Canada)　Novo Nordisk (Denmark)　Dallas Diabetes Research Center

来源Diabetologie und Stoffwechsel

年份2022

DOI10.1055/s-0042-1746282

原文https://doi.org/10.1055/s-0042-1746282

内容与影响

摘要 · 完整

Background Insulin icodec (icodec) is a novel basal insulin analogue in development as the first once-weekly insulin.

逐年被引趋势

210

223

关键指标

被引次数 · OpenAlex

0.27

领域内被引倍数
同类平均 = 1

前 43%

引用位次
同领域 · 同年份 · 同类型

参考文献

Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。

AI 辅助阅读

依据：摘要

论文问答

依据：摘要 · 当前未解析全文

回答优先基于摘要、文献信息与可获取全文；依据不足时会明确说明。

依据：当前详情页数据

学术脉络

学科主题

生物医学

Diabetes Management and Research

Hyperglycemia and glycemic control in critically ill and hospitalized patients · Diabetes Treatment and Management

参考文献 0

暂无参考文献明细

施引文献 3

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

Yuya Suzuki, Tianchen Zhao, Masaharu Tsubokura · New England Journal of Medicine · 2021

被引 3

<strong>Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review</strong>

Pranav M. Patel, Richard M. Abaniel, Natasha Dogra · 2023

被引 0